2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
21
Breast Neoplasms
20
Neoplasms
19
Stomach Neoplasms
15
Colorectal Neoplasms
15
Lung Neoplasms
13
Endometrial Neoplasms
13
Pancreatic Neoplasms
11
Leukemia, Myeloid, Acute
10
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Oropharyngeal Neoplasms
6
Neoplasm Metastasis
6
Multiple Myeloma
6
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Mouth Neoplasms
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Uterine Cervical Neoplasms
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Interventions
Temozolomide
159
Bevacizumab
69
Radiotherapy
68
Magnetic Resonance Spectroscopy
68
Irinotecan
31
Surgical Procedures, Operative
27
Radiation
24
Carboplatin
23
Specimen Handling
20
Carmustine
20
Blood Specimen Collection
20
Nivolumab
19
Aminolevulinic Acid
18
Biopsy
17
Lomustine
15
pembrolizumab
13
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
13
trametinib
12
fluorodopa F 18
12
X-Rays
12
Radiosurgery
12
Erlotinib Hydrochloride
12
Topotecan
11
Everolimus
11
Magnetic Resonance Imaging
10
IL13-PE38
10
dabrafenib
9
Etoposide
9
Drug Therapy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Observation
×
Clear all
NCT07025226
2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1
Recruiting
10 enrolled